Children and Sublingual Immunotherapy Safety Evidence
Sublingual immunotherapy shows a strong safety record in children ages 5–11.
Diego Lindqvist
Staff Writer
Diego Lindqvist
Diego Lindqvist is a staff writer at Modern Allergy Review covering allergy shots, drops, and tablets. Based in Bangalore, Diego has written for Modern Allergy Review since 2015.
1 story · Bangalore